Carboplatin News and Research

RSS
Carboplatin is a chemotherapy drug used against some forms of cancer (mainly ovarian carcinoma, lung, head and neck cancers).
FDA grants approval for new biosimilar to treat multiple types of cancer

FDA grants approval for new biosimilar to treat multiple types of cancer

Study: Chemoradiation should remain standard treatment for locally advanced cervical cancer

Study: Chemoradiation should remain standard treatment for locally advanced cervical cancer

Trial confirms standard three-week dosing of chemotherapy as first line treatment in ovarian cancer

Trial confirms standard three-week dosing of chemotherapy as first line treatment in ovarian cancer

FDA approves expanded use of Zykadia for first-line treatment of ALK-positive metastatic NSCLC

FDA approves expanded use of Zykadia for first-line treatment of ALK-positive metastatic NSCLC

Researchers identify DNA repair deficiency in many types of solid tumors

Researchers identify DNA repair deficiency in many types of solid tumors

Combination therapy may be effective option for treating some women with ovarian cancer

Combination therapy may be effective option for treating some women with ovarian cancer

ASTRO issues new clinical guideline for management of oropharyngeal cancer with radiation therapy

ASTRO issues new clinical guideline for management of oropharyngeal cancer with radiation therapy

KU researcher reveals possible therapeutic intervention for 'chemobrain' in cancer patients

KU researcher reveals possible therapeutic intervention for 'chemobrain' in cancer patients

Study finds biochemical pathway that triggers regrowth of breast cancer stem cells after chemotherapy

Study finds biochemical pathway that triggers regrowth of breast cancer stem cells after chemotherapy

Study addresses cost-effectiveness of checkpoint inhibitors for advanced melanoma in Hong Kong

Study addresses cost-effectiveness of checkpoint inhibitors for advanced melanoma in Hong Kong

I-SPY2 research initiative employs exciting new model for testing breast cancer drugs

I-SPY2 research initiative employs exciting new model for testing breast cancer drugs

First-line nivolumab promising in advanced NSCLC

First-line nivolumab promising in advanced NSCLC

Tandem myeloablative ASCT consolidation boosts neuroblastoma outcomes

Tandem myeloablative ASCT consolidation boosts neuroblastoma outcomes

Drug candidate delivered by plant-virus-based carrier shows promise for triple-negative breast cancer

Drug candidate delivered by plant-virus-based carrier shows promise for triple-negative breast cancer

Novel drug atezolizumab harnesses immune system to shrink tumors in advanced bladder cancer

Novel drug atezolizumab harnesses immune system to shrink tumors in advanced bladder cancer

Fasnall drug appears to inhibit tumor growth by promoting cancer cell death

Fasnall drug appears to inhibit tumor growth by promoting cancer cell death

Researchers find new clue to understanding 'chemo brain' in cancer patients

Researchers find new clue to understanding 'chemo brain' in cancer patients

Bayer-new phase 3 liver cancer data

Bayer-new phase 3 liver cancer data

Survivin inhibitor with chemotherapy provides therapeutic advantage for Rb cells, tumors

Survivin inhibitor with chemotherapy provides therapeutic advantage for Rb cells, tumors

Added benefit of crizotinib drug for first-line treatment of advanced bronchial carcinoma not proven

Added benefit of crizotinib drug for first-line treatment of advanced bronchial carcinoma not proven